Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

Similar articles for PubMed (Select 23886398)

1.

Impact of transient elastography on clinical decision-making in patients with chronic viral hepatitis.

Feuth T, Arends JE, Lieveld FI, Mundt MW, Hoepelman AI, Siersema PD, van Erpecum KJ.

Scand J Gastroenterol. 2013 Sep;48(9):1074-81. doi: 10.3109/00365521.2013.819441. Epub 2013 Jul 25.

PMID:
23886398
2.

Impact of Fibroscan on management of chronic viral hepatitis in clinical practice.

Fransen van de Putte D, Blom R, van Soest H, Mundt M, Verveer C, Arends J, de Knegt RE, Mauser-Bunschoten E, van Erpecum K.

Ann Hepatol. 2011 Oct-Dec;10(4):469-76.

3.

Treatment of patients with dual hepatitis C and B by peginterferon α and ribavirin reduced risk of hepatocellular carcinoma and mortality.

Liu CJ, Chu YT, Shau WY, Kuo RN, Chen PJ, Lai MS.

Gut. 2014 Mar;63(3):506-14. doi: 10.1136/gutjnl-2012-304370. Epub 2013 May 15.

PMID:
23676440
4.

Hepatitis G infection and therapeutic response to interferon in HCV-related chronic liver disease.

Pramoolsinsap C, Poovorawan Y, Sura T, Theamboonlers A, Busagorn N, Kurathong S.

Southeast Asian J Trop Med Public Health. 1998 Sep;29(3):480-90.

PMID:
10437943
5.

Significant liver damage in patients with bleeding disorders and chronic hepatitis C: non-invasive assessment of liver fibrosis using transient elastography.

Posthouwer D, Mauser-Bunschoten EP, Fischer K, VAN Erpecum KJ, DE Knegt RJ.

J Thromb Haemost. 2007 Jan;5(1):25-30.

PMID:
17239163
6.

Treatment of chronic hepatitis C in Asia: when East meets West.

Yu ML, Chuang WL.

J Gastroenterol Hepatol. 2009 Mar;24(3):336-45. doi: 10.1111/j.1440-1746.2009.05789.x. Review.

PMID:
19335784
7.

The usefulness of transient elastography in the assessment of patients with HBeAg-negative chronic hepatitis B virus infection.

Papatheodoridis GV, Manolakopoulos S, Margariti A, Papageorgiou MV, Kranidioti H, Katoglou A, Kontos G, Adamidi S, Kafiri G, Deutsch M, Pectasides D.

J Viral Hepat. 2014 Jul;21(7):517-24. doi: 10.1111/jvh.12176. Epub 2013 Oct 6.

PMID:
24750382
8.

Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma?

Lok AS.

J Gastroenterol Hepatol. 2011 Feb;26(2):221-7. doi: 10.1111/j.1440-1746.2010.06576.x.

PMID:
21070361
9.

The accuracy of noninvasive methods in predicting the development of hepatocellular carcinoma and hepatic decompensation in patients with chronic hepatitis B.

Chon YE, Jung ES, Park JY, Kim do Y, Ahn SH, Han KH, Chon CY, Jung KS, Kim SU.

J Clin Gastroenterol. 2012 Jul;46(6):518-25. doi: 10.1097/MCG.0b013e31825079f1.

PMID:
22688146
10.
11.

Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan).

Jung KS, Kim SU, Ahn SH, Park YN, Kim do Y, Park JY, Chon CY, Choi EH, Han KH.

Hepatology. 2011 Mar;53(3):885-94. doi: 10.1002/hep.24121. Epub 2011 Feb 11.

PMID:
21319193
12.

Assessment of liver fibrosis and cirrhosis by transient elastography among patients with chronic HBV and HCV infection in Georgia.

Tsertsvadze T, Dolmazashvili E, Abutidze A, Sharvadze L, Karchava M.

Georgian Med News. 2008 Dec;(165):38-42.

PMID:
19124915
13.

Prediction of liver complications in patients with hepatitis C virus-related cirrhosis with and without HIV coinfection: comparison of hepatic venous pressure gradient and transient elastography.

Pérez-Latorre L, Sánchez-Conde M, Rincón D, Miralles P, Aldámiz-Echevarría T, Carrero A, Tejerina F, Díez C, Bellón JM, Bañares R, Berenguer J.

Clin Infect Dis. 2014 Mar;58(5):713-8. doi: 10.1093/cid/cit768. Epub 2013 Nov 21.

14.

Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: a prospective study.

Ikeda K, Marusawa H, Osaki Y, Nakamura T, Kitajima N, Yamashita Y, Kudo M, Sato T, Chiba T.

Ann Intern Med. 2007 May 1;146(9):649-56.

PMID:
17470833
15.

The relationship between transient elastography and histological collagen proportionate area for assessing fibrosis in chronic viral hepatitis.

Isgro G, Calvaruso V, Andreana L, Luong TV, Garcovich M, Manousou P, Alibrandi A, Maimone S, Marelli L, Davies N, Patch D, Dhillon AP, Burroughs AK.

J Gastroenterol. 2013 Aug;48(8):921-9. doi: 10.1007/s00535-012-0694-9. Epub 2012 Nov 3.

PMID:
23124603
16.

The diagnostic accuracy of Fibroscan for cirrhosis is influenced by liver morphometry in HCV patients with a sustained virological response.

D'Ambrosio R, Aghemo A, Fraquelli M, Rumi MG, Donato MF, Paradis V, Bedossa P, Colombo M.

J Hepatol. 2013 Aug;59(2):251-6. doi: 10.1016/j.jhep.2013.03.013. Epub 2013 Mar 23.

PMID:
23528378
17.

Coinfections with hepatitis g and/or c virus in hepatitis B-related chronic liver disease.

Pramoolsinsap C, Sirikulchayanonta V, Busakorn W, Poovorawan Y, Hirsch P, Theamboonlers A, Lerdverasirikul P.

Southeast Asian J Trop Med Public Health. 1999 Dec;30(4):741-9.

PMID:
10928369
18.

Sustained HCV clearance by interferon-based therapy reduces hepatocellular carcinoma in hepatitis B and C dually-infected patients.

Hung CH, Lu SN, Wang JH, Hu TH, Chen CH, Huang CM, Lee CM.

Antivir Ther. 2011;16(7):959-68. doi: 10.3851/IMP1842.

PMID:
22024511
19.

Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus.

Tamori A, Nishiguchi S, Shiomi S, Hayashi T, Kobayashi S, Habu D, Takeda T, Seki S, Hirohashi K, Tanaka H, Kubo S.

Am J Gastroenterol. 2005 Aug;100(8):1748-53.

PMID:
16086711
20.

Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.

Rodríguez-Díaz JL, Rosas-Camargo V, Vega-Vega O, Morales-Espinosa D, Mendez-Reguera A, Martínez-Tlahuel JL, Gamboa-Domínguez A, Arrieta O.

Clin Oncol (R Coll Radiol). 2007 Apr;19(3):197-203. Epub 2007 Jan 18.

PMID:
17359907
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk